RESEARCH & STRATEGY

Kaveri Pohlman, PhD

Contact Us

Kaveri Pohlman, PhD, is a BTIG Biotechnology Analyst. She provides comprehensive coverage of the biotechnology sector with a focus on large and smidcap companies. Prior to BTIG, Dr. Pohlman was a Postdoctoral Research Associate at Weill Cornell Medical College, where her research work focused on understanding the pathogenesis of various subtypes of prostate cancer, defining the molecular biology underlying the disease progression, and identifying new therapeutic targets. She earned a PhD in molecular and cell biology from SUNY Downstate Medical Center, an MS in biotechnology from New York University’s Tandon School of Engineering, and an MBA from Birla Institute of Management Technology.

Back

Coverage Area

Company Ticker
Gritstone bio GRTS
G1 Therapeutics, Inc. GTHX
MacroGenics, Inc. MGNX
Arcus Biosciences, Inc. RCUS
Seagen Inc. SGEN
Xencor, Inc. XNCR
Mersana Therapeutics MRSN
Checkmate Pharmaceuticals CMPI
Replimune Group, Inc. REPL
BioAtla BCAB
Nuvation Bio NUVB
OncoSec Medical ONCS
Sonnet BioTherapeutics SONN